Gilead Sciences - Now That The COVID-19 Hype Is Over, Take A Look [Seeking Alpha]
Gilead Sciences, Inc. (GILD)
Last gilead sciences, inc. earnings: 4/30 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.gilead.com
Company Research
Source: Seeking Alpha
SummaryGilead Sciences has an impressive portfolio of assets - now that the company's share price has dropped post COVID-19 it's worth taking a second look.The company's core HIV portfolio is continuing to perform incredibly well, the company's legacy portfolios are earning cash, and the company's new drugs are exciting.We expect Gilead Sciences to continue generating significant cash flow which will translate to strong dividends and shareholder returns.Gilead Sciences (NASDAQ:GILDGilead Sciences - Financial TimesGilead Sciences Remdesivir ResultsGilead Sciences has been in the news recently for Remdesivir. Since the company's last earnings results, several things have become established. The first is that the costs of treatment have become fairly established. The second is that Remdesivir has been fairly well accepted as helping patients, but it's definitely not a cure.Gilead Sciences Selling Model - Gilead Sciences Investor PresentationGilead Sciences has already donated its entire
Show less
Read more
Impact Snapshot
Event Time:
GILD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GILD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GILD alerts
High impacting Gilead Sciences, Inc. news events
Weekly update
A roundup of the hottest topics
GILD
News
- Notable earnings after Thursday's close [Seeking Alpha]Seeking Alpha
- Gilead Sciences, Inc. (NASDAQ: GILD) was upgraded by analysts at HSBC Holdings plc from a "reduce" rating to a "hold" rating. They now have a $69.00 price target on the stock.MarketBeat
- Gilead Q1 Earnings Preview: Most Gains Wiped Out - Cause For Concern? [Seeking Alpha]Seeking Alpha
- Gilead (GILD) Gears Up to Report Q1 Earnings: What to Expect? [Yahoo! Finance]Yahoo! Finance
- Insights Into Gilead (GILD) Q1: Wall Street Projections for Key Metrics [Yahoo! Finance]Yahoo! Finance
GILD
Earnings
- 2/6/24 - Miss
GILD
Sec Filings
- 4/2/24 - Form 4
- 4/1/24 - Form 144
- 3/29/24 - Form 4
- GILD's page on the SEC website